Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2005
10/27/2005WO2005100371A1 Porous hybrid organic-inorganic materials for the detection of halogens
10/27/2005WO2005100235A1 Piezoresistive microcantilever sensor
10/27/2005WO2005099774A2 Diagnosis and treatment of myeloid and lymphoid cell cancers
10/27/2005WO2005099773A1 Use of erythropoietin for treatment of cancer
10/27/2005WO2005099772A2 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death
10/27/2005WO2005099747A1 Selective killing of cancer cells by induction of acetyltransferase via tnf-alpha and il-6
10/27/2005WO2005099746A1 Method for modulating appetite
10/27/2005WO2005099445A1 Controlled dilution system for drinking water and unit therefor
10/27/2005WO2005099441A1 Method of screening agrichemical capable of inducing disease resistance and plant for use in the method
10/27/2005WO2005099394A2 Methods and devices for microarray image analysis
10/27/2005WO2005099363A2 Methods of diagnosing, preventing and treating cancer metastasis
10/27/2005WO2005090992A3 Mptens as modifiers of the pten pathway and methods of use
10/27/2005WO2005090981A3 Electrode
10/27/2005WO2005089524A9 Compositions and methods for detection of single molecules
10/27/2005WO2005088286A3 Universal explosive material detector
10/27/2005WO2005083119A3 Hybridization method as well as hybridization microarray and hybridization kit
10/27/2005WO2005079834A9 Use of dmbt1 for capturing sulphate and phosphate group exposing agents
10/27/2005WO2005078440A3 Preparation of biologically derived fluids for biomarker determination by mass spectrometry
10/27/2005WO2005078434A3 Methods for forming palladium alloy thin films and optical hydrogen sensors employing palladium alloy thin films
10/27/2005WO2005076000A8 Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies
10/27/2005WO2005073254A3 Methods for inhibiting squamous cell carcinoma using antibodies against laminin
10/27/2005WO2005071421A8 Specific detection of troponin and modified forms of troponin
10/27/2005WO2005071393A3 Detecting element and detection method
10/27/2005WO2005069014A9 Method and apparatus for testing cement slurries
10/27/2005WO2005068985A3 Method and device for the optical monitoring of a running fiber strand
10/27/2005WO2005065411A9 Test apparatus for direct measurement of expansion and shrinkage of oil well cements
10/27/2005WO2005063966A3 Method for in vitro differentiation of neuronal stem cells or cells derived from neuronal stem cells
10/27/2005WO2005063335B1 MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS
10/27/2005WO2005060375A3 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
10/27/2005WO2005059565A3 Method for the determination of 25-hydroxycholecalciferol in feed
10/27/2005WO2005059563A3 Method for analyzing a glycomolecule
10/27/2005WO2005059554A8 Puma, phosphorylated p53 and p38 map kinase as markers for hiv-1-induced apoptosis in circulating t cells of infected patient
10/27/2005WO2005044838A8 Cd4+ epitopes of bone morphogenetic proteins
10/27/2005WO2005043110A3 Fluorescence assay for mtp activity
10/27/2005WO2005040835A3 Method for determining the antiradical defense potential and use thereof, in particular in veterinary and human preventive therapeutics
10/27/2005WO2005040338A3 Constrained alkaloid immunogens and antibodies and uses thereof
10/27/2005WO2005033665A3 Semi-automated microscopic assessment of islet quantity, equivalence and purity
10/27/2005WO2005017207A3 Methods and compositions for detecting colon cancers
10/27/2005WO2005017122A3 Biocompatibile linkers for surface plasmon resonance biosensors
10/27/2005WO2005009374A3 Ceramide dependent-stabilization of bace1
10/27/2005WO2005009225A3 Tissue adhesive sealant
10/27/2005WO2004113870A3 Time domain resolving chemical sampler using sorbent material
10/27/2005WO2004111641A3 Methods for detecting cancer and monitoring cancer progression
10/27/2005WO2004100890A3 Rage g82s-related methods and compositions for treating inflammatory disorders
10/27/2005WO2004094598A3 Methods of use for novel human polypeptides encoded by polynucleotides
10/27/2005WO2004070388A8 Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases
10/27/2005WO2004070353A3 Method and apparatus for processing assay test results
10/27/2005WO2004068109A3 Autologous or homologous coagulant produced from anticoagulated whole blood
10/27/2005WO2004055517A3 Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
10/27/2005WO2003102016A3 Amyloid peptide inactivating enzyme to treat alzheimer's disease
10/27/2005WO2003072595A3 Methods and products based on oligomerization of stress proteins
10/27/2005WO2003029277A3 Modulators of lymphocyte activation and migration
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005WO2002057313A8 Receptor-binding compounds and methods for identifying them
10/27/2005US20050241012 Multigene profiling in the kidney to tailor drug therapy
10/27/2005US20050241008 Transgenic models of Alzheimer's disease and uses therefor in the treatment of a variety of neurodegenerative diseases
10/27/2005US20050240611 Recording medium and blood glucose monitoring system using the recording medium
10/27/2005US20050240592 Real time data integration for supply chain management
10/27/2005US20050240360 Method and device for measuring physical characteristics of a solid porous sample
10/27/2005US20050240358 Genome information display system
10/27/2005US20050240357 Methods and systems for differential clustering
10/27/2005US20050240356 Method and device for monitoring an analyte concentration in the living body of a human or animal
10/27/2005US20050240354 Service oriented architecture for an extract function in a data integration platform
10/27/2005US20050240353 Reagents, devices and methods for proteomic analysis with applications including diagnostics, vaccines, quality control and research
10/27/2005US20050240352 Online procurement of biologically related products/services using interactive context searching of biological information
10/27/2005US20050240119 Blood glucose meter having integral lancet device and test strip storage vial for single handed use and methods for using same
10/27/2005US20050240115 Sample conditioning and environmental control techniques for gas sensor
10/27/2005US20050240092 Infusion devices, glucose meters and/or monitors with smell sniffing technology
10/27/2005US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease
10/27/2005US20050239821 Viral inhibitors
10/27/2005US20050239217 Fluorogenic homogeneous binding assay methods and compositions
10/27/2005US20050239216 Multi-functional and configurable assay
10/27/2005US20050239215 Method for quantitatively detecting antigen
10/27/2005US20050239214 Enhance chromatographic detection by providing component stability and controlled release; for rapid detection of analytes in a sample
10/27/2005US20050239213 Molybdenum complex & test kit to enhance accuracy of analysis of endogenous analytes in biological fluids
10/27/2005US20050239210 Analytical chip and analytical apparatus
10/27/2005US20050239209 Method for peptide and polypeptide purification and differential analysis
10/27/2005US20050239208 Adding an exogenous antioxidant compound to a lipid-containing test food substrate; then adding a diazo-type free radical source, heating, comparing products of oxidation produced in a control lipid-containing food treated in the same way as the test but without an exogenous antioxidant
10/27/2005US20050239206 Sample is exposed to carbon monoxide, transition metals, if present in or on the sample and are extracted by the carbon monoxide as metal carbonyl species, the presence of which confirms the presence of transition metals; for use in oil and gas exploration
10/27/2005US20050239203 Regulation of endogenous gene expression in cells using zinc finger proteins
10/27/2005US20050239194 Apparatus for purification, quantitative analysis and separation of molecules such as proteins in gels, detection using detectors comprising optics having high and low refractive index material, electroconductive films, metal sheets and immobilized receptor
10/27/2005US20050239193 Device and method of use for detection and characterization of microorganisms and microparticles
10/27/2005US20050239186 Peptidyl-tRNA hydrolase of Enterococcus faecalis
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050239160 Method for identification of proteins from intracellular bacteria
10/27/2005US20050239158 Enzyme-based monitoring device for thermal processing of objects
10/27/2005US20050239156 Blood glucose tracking apparatus and methods
10/27/2005US20050239155 Entrapped binding protein as biosensors
10/27/2005US20050239153 ADAMTS-13-catalyzed proteolysis of VWF; detected by the ability of the VWF to aggregate platelets
10/27/2005US20050239152 Continuous-flow enzyme assay
10/27/2005US20050239151 Method of detecting an antibody in a liquid sample
10/27/2005US20050239150 Method for diagnosing sepsis by determining anti-asialogangliside antibodies
10/27/2005US20050239149 A water soluble macromolecular quaternary ammonium salt, a quaternary sulfonium salt or a quaternary phosphonium salt, pretreated with an oxidizing agent or a reducing agent, is used to enhance emission of light caused by an enzymatic reaction of a chemiluminescent substrate composed of a dioxetane,
10/27/2005US20050239147 Exposing a test sample from an animal, e.g., bovine, to a population of microorganisms, especially killed Mycobacterium avium subsp. paratuberculosis, and determining if the test sample contains an antibody that binds to the microorganism, preferably to the surface of the microorganism
10/27/2005US20050239146 Neoepitope detection of disease using protein arrays
10/27/2005US20050239145 Flow-through membrane assays for carbohydrates using labeled lectins
10/27/2005US20050239144 Site-specific labelling of proteins using cyanine dye reporters
10/27/2005US20050239143 Immunocapture-based measurements of mammalian pyruvate dehydrogenase complex
10/27/2005US20050239141 Modified antibody variable domains
1 ... 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 ... 3937